Skip Navigation



Cardiovascular Research Advance Access [Accepted Manuscript] published online on February 20, 2009
Cardiovascular Research, doi:10.1093/cvr/cvp064
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
82/2/212    most recent
cvp064v2
cvp064v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Igarashi, J.
Right arrow Articles by Michel, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Igarashi, J.
Right arrow Articles by Michel, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org.

Sphingosine 1-phosphate and modulation of vascular tone

Junsuke Igarashi1,{ddagger} and Thomas Michel2,{ddagger}

1 Department of Cardiovascular Physiology, Kagawa University, Kagawa, Japan
2 Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115

{ddagger} Addresses for Correspondence: Junsuke Igarashi, M.D., Ph.D., Dept. of Cardiovascular Physiology, Kagawa University Faculty of Medicine, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793 Japan Telephone: 81-87-891-2099, FAX: 81-87-891-2101 email: igarashi{at}med.kagawa-u.ac.jp, Thomas Michel, M.D., Ph.D., Cardiovascular Division, Brigham and Women's Hospital, Thorn Building, Room 1210A, 75 Francis Street, Boston, MA 02115, Telephone: 1-617-732-7376, FAX: 1-617-732-5132, email: thomas_michel{at}harvard.edu

Sphingosine 1-phosphate (S1P) is a phosphorylated product of sphingosine, the core structure of the class of lipids termed sphingolipids. S1P is a naturally occurring lipid metabolite, and usually is present at a concentration of a few hundred nanomolar in human sera. S1P has been found to exert a diverse set of physiological and pathophysiological responses in mammalian tissues through the activation of heterotrimeric G-proteins that in turn modulate the activity of various downstream effecter molecules. In blood vessels, vascular endothelial cells and smooth muscle cells express specific receptors for S1P that modulate vascular tone. This article will provide a brief overview of S1P metabolism in the vasculature, and will discuss some of the pathways whereby S1P regulates intracellular signal transduction pathways in endothelial and smooth muscle cells, leading to the activation of both vasorelaxation and vasoconstriction responses.

KEYWORDS vasoactive agents; lipid signaling; receptors; G-proteins; eNOS

Time for primary review: 36 Days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
J. S. Karliner and J. H. Brown
Lipid signalling in cardiovascular pathophysiology
Cardiovasc Res, May 1, 2009; 82(2): 171 - 174.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.